IP Library › Granted Patent US 10,118,980
Granted Patent B1
US 10,118,980 · App. 15/604,529 · Granted Nov 6, 2018

Polymer particles

Inventors: Steve Plotkin (Tustin, CA); Gregory M. Cruise (Rancho Santa Margarita, CA); Edward Michael Keeley (Huntington Beach, CA); Renee Yu (Tustin, CA); Clayton Harris (Irviine, CA)
Assignee: Terumo Corporation
C08F220/28A61K31/704A61K47/32A61L24/0015A61L24/06C08F220/38C08G65/33324A61L2300/418C08F2220/282C08F2220/382
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,118,980
App. No.
15/604,529
Granted
Nov 6, 2018
Kind
B1
Abstract

Polymer particle embolics and methods of making same are described. The particle embolics can be used as embolization agents.

Claims (26)

1. A polymer particle comprising:

at least one derivatized poly(ethylene glycol) macromer, poly(propylene glycol) macromer, poly(tetramethylene oxide) macromer, or a combination thereof at a concentration of between about 15% w/w and about 50% w/w; and

at least one monomer including glycerol monomethacrylate, amino ethyl methacrylate, 3-sulfopropyl acrylate, amino propyl methacrylamide, or a combination thereof, wherein the monomer is not n-isopropyl acrylamide,

wherein the polymer particle is spherical and has a diameter less than about 1,200 μm.

2. The polymer particle of claim 1 , wherein the polymer particle has a diameter between about 40 μm and about 1,200 μm.

3. The polymer particle of claim 1 , further comprising at least one additional monomer that is not n-isopropyl acrylamide.

4. The polymer particle of claim 3 , wherein the at least one monomer includes a functional group, wherein the functional group is acrylate, acrylamide, methacrylate, or methacrylamide.

5. The polymer particle of claim 1 , wherein the at least one monomer is glycerol monomethacrylate at a concentration of about 68% w/w.

6. The polymer particle of claim 1 , wherein the at least one monomer is 3-sulfopropyl acrylate at a concentration of about 59% w/w.

7. The polymer particle of claim 1 , wherein the at least one monomer is amino propyl methacrylamide at a concentration of about 1% w/w.

8. The polymer particle of claim 1 , wherein the at least one monomer is amino ethyl methacrylate at a concentration of about 3% w/w.

9. The polymer particle of claim 1 , wherein the at least one derivatized poly(ethylene glycol) macromer is poly(ethylene glycol) diacrylamide, poly(ethylene glycol) diacrylate, poly(ethylene glycol) dimethacrylate, poly(ethylene glycol) dimethacrylamide, or a combination thereof.

10. The polymer particle of claim 1 , wherein the at least one derivatized poly(ethylene glycol) macromer is poly(ethylene glycol) diacrylamide 10,000.

11. A polymer particle comprising:

at least one derivatized poly(ethylene glycol) macromer, poly(propylene glycol) macromer, poly(tetramethylene oxide) macromer, or a combination thereof at a concentration of between about 15% w/w and about 50% w/w, wherein the at least one derivatized poly(ethylene glycol) macromer is poly(ethylene glycol) diacrylamide, poly(ethylene glycol) diacrylate, poly(ethylene glycol) dimethacrylate, poly(ethylene glycol) dimethacrylamide, or a combination thereof; and

at least one monomer that is not n-isopropyl acrylamide,

wherein the polymer particle is spherical and has a diameter less than about 1,200 μm.

12. The polymer particle of claim 11 , wherein the polymer particle has a diameter between about 40 μm and about 1,200 μm.

13. The polymer particle of claim 11 , further comprising at least one additional monomer that is not n-isopropyl acrylamide.

14. The polymer particle of claim 11 , wherein the at least one monomer includes a functional group, wherein the functional group is acrylate, acrylamide, methacrylate, or methacrylamide.

15. The polymer particle of claim 11 , wherein the at least one monomer is glycerol monomethacrylate, amino ethyl methacrylate, 3-sulfopropyl acrylate, amino propyl methacrylamide, or a combination thereof.

16. The polymer particle of claim 15 , wherein the at least one monomer is glycerol monomethacrylate at a concentration of about 68% w/w.

17. The polymer particle of claim 15 , wherein the at least one monomer is 3-sulfopropyl acrylate at a concentration of about 59% w/w.

18. The polymer particle of claim 16 , wherein the at east one monomer is amino propyl methacrylamide at a concentration of about 1% w/w.

19. The polymer particle of claim 15 , wherein the at least one monomer is amino ethyl methacrylate at a concentration of about 3% w/w.

20. The polymer particle of claim 11 , wherein the at least one derivatized poly(ethylene glycol) macromer is poly(ethylene glycol) diacrylamide 10,000.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2017
From: PLOTKIN, STEVE; CRUISE, GREGORY M.; KEELEY, EDWARD MICHAEL; YU, RENEE; HARRIS, CLAYTON
To: MICROVENTION, INC.
Reel/Frame 042499/0798 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2017
From: MICROVENTION, INC.
To: TERUMO CORPORATION
Reel/Frame 042499/0848 →
Continuity (2)
Continuation 14536394 · Nov 7, 2014
Provisional Application 61902020 · Nov 8, 2013
Cited By (2)
US 12,364,786 US 12,447,228